देश: नीदरलैंड
भाषा: डच
स्रोत: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
METFORMINEHYDROCHLORIDE 850 mg/stuk SAMENSTELLING overeenkomend met ; METFORMINE 662,6 mg/stuk ; SITAGLIPTINEHYDROCHLORIDE 1-WATER 56,7 mg/stuk SAMENSTELLING overeenkomend met ; SITAGLIPTINE 50 mg/stuk
METFORMINEHYDROCHLORIDE 850 mg/stuk SAMENSTELLING overeenkomend met ; METFORMINE 662,6 mg/stuk ; SITAGLIPTINEHYDROCHLORIDE 1-WATER 56,7 mg/stuk SAMENSTELLING overeenkomend met ; SITAGLIPTINE 50 mg/stuk
Filmomhulde tablet
CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; NATRIUMLAURILSULFAAT ; NATRIUMSTEARYLFUMARAAT ; POVIDON K 30 (E 1201) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171) ; TRIETHYLCITRAAT (E 1505), CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROLOSE (E 463) ; HYPROMELLOSE, Type 2910 (3 - 15 mPa.s) (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; NATRIUMLAURILSULFAAT (E 487) ; NATRIUMSTEARYLFUMARAAT ; POVIDON K 30 (E 1201) ; TALK (E 553 B) ; TITAANDIOXIDE (E 171) ; TRIETHYLCITRAAT (E 1505)
Oraal gebruik
1900-01-01
Sandoz B.V. Page 1/9 Sitagliptine/Metformine HCL Sandoz 50/850, 50/1000 mg, filmomhulde tabletten RVG 125725-6 1313-v4a 1.3.1.3 Leaflet Mei 2023 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SITAGLIPTINE/METFORMINE HCL SANDOZ 50/850 MG, FILMOMHULDE TABLETTEN SITAGLIPTINE/METFORMINE HCL SANDOZ 50/1000 MG, FILMOMHULDE TABLETTEN sitagliptine/metforminehydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What {[Nationally completed name]} is and what it is used for 2. What you need to know before you take {Nationally completed name]} 3. How to take {Nationally completed name]} 4. Possible side effects 5. How to store {Nationally completed name]} 6. Contents of the pack and other information 1. WHAT {NATIONALLY COMPLETED NAME]} IS AND WHAT IT IS USED FOR {[Nationally completed name]} contains two different medicines called sitagliptin and metformin. • sitagliptin belongs to a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) • metformin belongs to a class of medicines called biguanides. They work together to control blood sugar levels in adult patients with a form of diabetes called ‘type 2 diabetes mellitus’. This medicine helps to increase the levels of insulin produced after a meal and lowers the amount of sugar made by your body. Along with diet and exercise, this medicine helps lower your blood sugar. This medicine can be used alone or with certain other medicines for diabetes (insulin, sulphonylureas, or glitazones). Sandoz B.V. Page 2/9 Sit पूरा दस्तावेज़ पढ़ें
Sandoz B.V. Page 1/24 Sitagliptine/Metformine Sandoz 50/850, 50/1000 mg, filmomhulde tabletten RVG 125725-6 1311-v1 1.3.1.1 Summary of Product Characteristics April 2021 SAMENVATTING VAN DE PRODUCTKENMERKEN 1. NAME OF THE MEDICINAL PRODUCT Sitagliptine/Metformine HCl Sandoz 50/850 mg, filmomhulde tabletten Sitagliptine/Metformine HCl Sandoz 50/1000 mg, filmomhulde tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION {[NATIONALLY COMPLETED NAME] 50 MG/850 MG FILM-COATED TABLETS}: Each film-coated tablet contains sitagliptin hydrochloride monohydrate equivalent to 50 mg of sitagliptin, and 850 mg of metformin hydrochloride. {[NATIONALLY COMPLETED NAME] 50 MG/1,000 MG FILM-COATED TABLETS}: Each film-coated tablet contains sitagliptin hydrochloride monohydrate equivalent to 50 mg of sitagliptin, and 1,000 mg of metformin hydrochloride. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet (tablet). {[NATIONALLY COMPLETED NAME] 50 MG/850 MG FILM-COATED TABLETS}: Light orange film-coated tablet of oval, biconvex shape (approximately 10x20 mm), debossed with “SM 2” on one side. {[NATIONALLY COMPLETED NAME] 50 MG/1,000 MG FILM-COATED TABLETS}: Light red film-coated tablet of oval, biconvex shape (approximately 10.5x21 mm), debossed with “SM 3” on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For adult patients with type 2 diabetes mellitus: {[Nationally completed name]} is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. {[Nationally completed name]} is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea. Sandoz B.V. Page 2/24 Sitagliptine/Metformine Sandoz 50/850, 50/1000 mg, filmomhulde tabletten RVG 1257 पूरा दस्तावेज़ पढ़ें